Killing of Leishmania donovani Amastigotes by Poly ICLC in Hamsters
- 1 April 1996
- journal article
- Published by Mary Ann Liebert Inc in Journal of Interferon & Cytokine Research
- Vol. 16 (4) , 321-325
- https://doi.org/10.1089/jir.1996.16.321
Abstract
In vitro as well as in vivo studies suggest that cytokine-induced synthesis of nitric oxide (NO) from L-arginine is a major effector mechanism against intracellular pathogens. In this study, we demonstrate that golden hamsters infected with Leishmania donovani amastigotes upon treatment with polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose (poly ICLC), a potent interferon inducer and immune enhancer, in combination with L-arginine, develop the capacity to eliminate intracellular pathogens. This antileishmanial activity of poly ICLC was suppressed by N w nitro-L-arginine (N w NLA), an inhibitor of inducible NO synthase. Furthermore, prolonged treatment of infected animals with L-arginine alone for 5 days more after 5 day treatment with poly ICLC plus L-arginine increased the antileishmanial activity compared with 5 day treatment with poly ICLC plus L-arginine, suggesting that inducible NO synthase, once activated, produces NO for 5 days more. Our results suggest that an L-arginine-dependent, NO-mediated mechanism is probably responsible for the antileishmanial action of poly ICLC.Keywords
This publication has 19 references indexed in Scilit:
- Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major.The Journal of Experimental Medicine, 1994
- The arginine‐nitric oxide pathway: A target for new drugsMedicinal Research Reviews, 1994
- Practical progress and new drugs for changing patterns of leishmaniasisParasitology Today, 1993
- Nonspecific defence the role of nitric oxideParasitology Today, 1991
- Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense in vitro, in animal models, and in humansDiagnostic Microbiology and Infectious Disease, 1990
- Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.The Journal of Experimental Medicine, 1990
- Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.The Journal of Experimental Medicine, 1989
- Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages.Journal of Clinical Investigation, 1988
- The respiratory burst is not required for killing of intracellular and extracellular parasites by a lymphokine‐activated macrophage cell lineEuropean Journal of Immunology, 1985
- Susceptibility of leishmania to oxygen intermediates and killing by normal macrophagesThe Journal of Experimental Medicine, 1981